Fatal rebleeding following coil embolization of cerebral aneurysms: the role of long-term systemic anticoagulation. Neuroradiology 2001 May;43(5):398-404
Date
06/09/2001Pubmed ID
11396746DOI
10.1007/s002340000497Scopus ID
2-s2.0-0035022121 (requires institutional sign-in at Scopus site) 9 CitationsAbstract
Embolization of cerebral aneurysms has become a common technique. Its impact on subsequent medical management of the patient is not well known. We report two patients who presented in a poor neurological grade after subarachnoid hemorrhage from posterior communicating artery aneurysms. Both were treated by coil embolization and both developed subclavian vein thrombosis, requiring systemic anticoagulation, initiated 11 and 21 days after embolization, respectively. Both developed a large, fatal intracranial hemorrhage adjacent to the embolized aneurysm in the fourth week of anticoagulation. Systemic anticoagulation of patients who have had a ruptured aneurysm treated by coil embolization may carry a significant risk of rebleeding. Alternate management strategies should be considered in these patients.
Author List
Sinson G, Bagley LJ, Flamm ES, Hurst RWAuthor
Grant P. Sinson MD Associate Professor in the Neurosurgery department at Medical College of WisconsinMESH terms used to index this publication - Major topics in bold
AgedAnticoagulants
Cerebral Hemorrhage
Embolization, Therapeutic
Fatal Outcome
Female
Humans
Intracranial Aneurysm
Middle Aged
Recurrence
Time Factors